Evaluation of intrapatient variability in bioavailability of Technosphere insulin compared with subcutaneous regular insulin in patients with type 2 diabetes.
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2011
At a glance
- Drugs Insulin; Insulin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 31 Aug 2018 Biomarkers information updated
- 28 Jun 2011 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
- 14 Aug 2007 New trial record.